ClassID:

95280

C07D411/04 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Recent Application in this class:
#1
20250385321
2025-12-18

ELECTROLYTE, SECONDARY BATTERY, AND ELECTRIC APPARATUS

#2
20240398803
2024-12-05

COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGRADATION

#3
20240269140
2024-08-15

Compositions and methods for treating retinal degradation

#4
20240245675
2024-07-25

PROTEIN SECRETION INHIBITORS

#5
20240043413
2024-02-08

COMPOUNDS AND APPLICATIONS THEREOF IN FIELD OF OPTOELECTRONICS

#6
20230399302
2023-12-14

PROCESS FOR THE PREPARATION OF HETEROARYL-SUBSTITUTED SULFUR(VI) COMPOUNDS

#7
20230218620
2023-07-13

Compositions and methods for treating retinal degradation

#8
20220211714
2022-07-07

COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTICS

#9
20210408603
2021-12-30

Electrolytic solution, and electrochemical device using the same

#10
20210085681
2021-03-25

Compositions and methods for treating retinal degradation

#11
20210052573
2021-02-25

Oxo-tetrahydro-isoquinoline carboxylic acids as STING inhibitors

#12
20200040015
2020-02-06

Prodrug compositions

#13
20190255049
2019-08-22

Compositions and methods for treating retinal degradation

#14
20190211004
2019-07-11

Process for producing Lamivudine and Emtricitabine

#15
20190047968
2019-02-14

6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES

#16
20190040042
2019-02-07

Substituted 2-oxyimidazolylcarboxamides as pesticides

#17
20180108844
2018-04-19

Organic electroluminescent materials and devices

#18
20180044327
2018-02-15

Compositions and methods for treating retinal degradation

#19
20170304308
2017-10-26

Compositions and methods for the delivery of therapeutics

#20
20170290795
2017-10-12

URAT1 inhibitor

#21
20170253584
2017-09-07

Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives

#22
20170129861
2017-05-11

6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides

#23
20170044133
2017-02-16

2-amino-pyridine and 2-amino-pyrimidine derivatives and medicinal use thereof

#24
20160322584
2016-11-03

Method for preparing conjugated compound having phenoxathiin and electron donating group of conjugated aromatic unit, and OLED device having the conjugated compound

#25
20160311843
2016-10-27

Substituted nucleoside derivatives with antiviral and antimicrobial properties

#26
20160263114
2016-09-15

Compositions and methods for treating retinal degradation

#27
20160237059
2016-08-18

HETEROCYCLIC SUBSTITUTED TRIFLUOROMETHYL PYRIMIDINONES AND THEIR USE

#28
20160185772
2016-06-30

Arginine methyltransferase inhibitors and uses thereof

#29
20160168139
2016-06-16

Morpholine derivative or salt thereof

#30
20160129122
2016-05-12

FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES

#31
20160024061
2016-01-28

PREPARATION OF 2'-FLUORO-2'-ALKYL-SUBSTITUTED OR OTHER OPTIONALLY SUBSTITUTED RIBOFURANOSYL PYRIMIDINES AND PURINES AND THEIR DERIVATIVES

#32
20150368232
2015-12-24

Lamivudine salts

#33
20150322018
2015-11-12

Substituted pyridazines as skeletal muscle modulators

#34
20150203457
2015-07-23

6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides

#35
20150168830
2015-06-18

ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM USING THE SAME, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE AND ELECTRONIC DEVICE, AND COMPOUND

#36
20150065527
2015-03-05

Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors

#37
20150005257
2015-01-01

Arylalkyloxy pyrimidine derivative, pesticide for agricultural and horticultural use containing arylalkyloxy pyrimidine derivative as active ingredient, and use of same

#38
20150005165
2015-01-01

Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof and use thereof as herbicides and plant growth regulators

#39
20140288105
2014-09-25

Arginine methyltransferase inhibitors and uses thereof

#40
20140274701
2014-09-18

4-amino-6-(heterocyclic)picolinates and 6-amino-2-(heterocyclic)pyrimidine-4-carboxylates and their use as herbicides

#41
20140094475
2014-04-03

Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof

#42
20140046062
2014-02-13

PROCESS FOR NUCLEOSIDES

#43
20140045687
2014-02-13

Use of substituted dithiine-dicarboximides for combating phytopathogenic fungi

#44
20130338349
2013-12-19

PREPARATION OF 2'-FLUORO-2'-ALKYL-SUBSTITUTED OR OTHER OPTIONALLY SUBSTITUTED RIBOFURANOSYL PYRIMIDINES AND PURINES AND THEIR DERIVATIVES

#45
20130296562
2013-11-07

STEREOSELECTIVE PROCESS FOR PREPARATION OF 1,3-OXATHIOLANE NUCLEOSIDES

#46
20130143862
2013-06-06

Amino-pyridazine skeletal muscle modulators

#47
20130102468
2013-04-25

6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides

#48
20130072681
2013-03-21

Process for stereoselective synthesis of 5-fluoro-1-(2R,5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

#49
20130053560
2013-02-28

Lamivudine oxalate and preparation method thereof

#50
20120316339
2012-12-13

Preparation of lamivudine form I

#51
20120295930
2012-11-22

NOVEL PROCESS FOR THE PREPARATION OF CIS-NUCLEOSIDE DERIVATIVE

#52
20120232064
2012-09-13

Aspartyl protease inhibitors

#53
20120157425
2012-06-21

Compounds, pharmaceutical compositions and uses thereof

#54
20110288298
2011-11-24

NOVEL POLYMORPH OF EMTRICITABINE AND A PROCESS FOR PREPARING OF THE SAME

#55
20110282046
2011-11-17

PROCESS FOR PREPARATION OF CIS-NUCLEOSIDE DERIVATIVE

#56
20110268822
2011-11-03

METHODS FOR SYNTHESIZING KOTALANOL AND STEREOISOMERS AND ANALOGUES THEREOF, AND NOVEL COMPOUNDS PRODUCED THEREBY

#57
20110257397
2011-10-20

Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1′-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof

#58
20110257396
2011-10-20

PROCESS FOR THE MANUFACTURE OF CIS(-)-LAMIVUDINE

#59
20110257014
2011-10-20

1-(Heteroaryl)pyrazol-4-ylacetic acids, processes for their preparation and their use as herbicides and plant growth regulators

#60
20110245497
2011-10-06

OPTICAL RESOLUTION OF SUBSTITUTED 1, 3-OXATHIOLANE NUCLEOSIDES

#61
20110137034
2011-06-09

Process for preparing lamivudine polymorph form

#62
20110118465
2011-05-19

PROCESS FOR STEREOSELECTIVE SYNTHESIS OF LAMIVUDINE

#63
20110039798
2011-02-17

Substituted nucleoside derivatives with antiviral and antimicrobial properties

#64
20100324290
2010-12-23

CRYSTALLINE FORM I OF LAMIVUDINE AND ITS PREPARATION

#65
20100311970
2010-12-09

PROCESS FOR THE PREPARATION OF SUBSTITUTED 1,3-OXATHIOLANES

#66
20100311961
2010-12-09

PROCESS AND INTERMEDIATES FOR THE PREPARATION OF SUBSTITUTED 1,3-OXATHIOLANES, ESPECIALLY LAMIVUDINE

#67
20100305321
2010-12-02

Process for chiral resolution of 2-substituted 4-substituted 1,3-oxathiolanes

#68
20100256372
2010-10-07

Process for producing 5-fluoro-1-(2R, 5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

#69
20100249409
2010-09-30

Process for stereoselective synthesis of lamivudine

#70
20100240883
2010-09-23

Lipid-drug conjugates for drug delivery

#71
20100216767
2010-08-26

QUINAZOLINES FOR PDK1 INHIBITION

#72
20100190982
2010-07-29

PROCESS FOR THE PREPARATION OF LAMIVUDINE FORM I

#73
20100120804
2010-05-13

Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors

#74
20100063283
2010-03-11

Process for stereoselective synthesis of lamivudine

#75
20090306114
2009-12-10

Polymorphic and other crystalline forms of cis-FTC

#76
20090281053
2009-11-12

Crystalline form of lamivudine

#77
20090246819
2009-10-01

Assay methods using chemiluminescent detection of peroxidase

#78
20090239887
2009-09-24

Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers

#79
20090192310
2009-07-30

Process and intermediates for preparing emtricitabine

#80
20090048190
2009-02-19

Antiviral activity and resolution of 2-hydroxymethyl-5(5-fluorocytosin-1-yl)-1,3-oxathiolane

#81
20090036679
2009-02-05

METHOD FOR RESOLVING ENANTIOMERS FROM RACEMIC MIXTURE HAVING CHIRAL CARBON IN ALPHA POSITION OF NITROGEN

#82
20080187580
2008-08-07

Therapeutic nucleosides

#83
20080132558
2008-06-05

1-arylpyrazoles and their use as pesticide

#84
20070287692
2007-12-13

Aspartyl protease inhibitors

#85
20070238875
2007-10-11

HETEROCYCLIC COMPOUNDS

#86
20070037977
2007-02-15

Substituted-1, 3-oxathiolanes and substituted-1, 3-dioxolanes with antiviral properties

#87
20070037975
2007-02-15

Substituted-1,3-oxathiolanes and substituted-1, 3-dioxolanes with antiviral properties

#88
20070015775
2007-01-18

HETEROCYCLIC COMPOUNDS

#89
20060276492
2006-12-07

Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane

#90
20060229327
2006-10-12

Therapeutic nucleosides

#91
20060199786
2006-09-07

Process and methods for the preparation of optically active cis-2-hydroxymethyl-4- (cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof

#92
20060189805
2006-08-24

Process and intermediates for preparing emtricitabine

#93
20060183899
2006-08-17

Stereoselective method for the preparation of nucleosides

#94
20060142318
2006-06-29

Compounds for treating fundic disaccomodation

#95
20060122146
2006-06-08

Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives

#96
20050250950
2005-11-10

1,3-oxathiolane nucleoside analogues

#97
20050215527
2005-09-29

Antiviral activity and resolution of 2-hydroxymethyl-5- (5-fluorocytosin-1-yl)-1, 3-oxathiolane

#98
20050176767
2005-08-11

Pyridine carboxamide and methods for inhibiting HIV integrase

#99
20050158815
2005-07-21

Assay methods using chemiluminescent detection of peroxidase

#100
20050137191
2005-06-23

Nitrate esters and their use for mitigating cellular damage

#101
20050130996
2005-06-16

Heterocyclic compounds

#102
20050056293
2005-03-17

Reduced ignition propensity smoking article

#103
20050026934
2005-02-03

Polymorphic and other crystalline forms of cis-FTC

#104
20050004148
2005-01-06

Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane